Edinburgh Shoulder Clinic, Royal Infirmary of Edinburgh, Edinburgh, UK.
Bone Joint J. 2022 Jan;104-B(1):157-167. doi: 10.1302/0301-620X.104B1.BJJ-2021-0675.R1.
Open reduction and plate fixation (ORPF) for displaced proximal humerus fractures can achieve reliably good long-term outcomes. However, a minority of patients have persistent pain and stiffness after surgery and may benefit from open arthrolysis, subacromial decompression, and removal of metalwork (ADROM). The long-term results of ADROM remain unknown; we aimed to assess outcomes of patients undergoing this procedure for stiffness following ORPF, and assess predictors of poor outcome.
Between 1998 and 2018, 424 consecutive patients were treated with primary ORPF for proximal humerus fracture. ADROM was offered to symptomatic patients with a healed fracture at six months postoperatively. Patients were followed up retrospectively with demographic data, fracture characteristics, and complications recorded. Active range of motion (aROM), Oxford Shoulder Score (OSS), and EuroQol five-dimension three-level questionnaire (EQ-5D-3L) were recorded preoperatively and postoperatively.
A total of 138 patients underwent ADROM; 111 patients were available for long-term follow-up at a mean of 10.9 years (range 1 to 20). Mean age was 50.8 years (18 to 75);79 (57.2%) were female. Mean time from primary ORPF to ADROM was 11.9 months (6 to 19). Five patients developed superficial wound infection; ten developed symptomatic osteonecrosis/post-traumatic arthrosis (ON/PTA); four underwent revision arthrolysis. Median OSS improved from 17 (interquartile range (IQR) 12.0 to 22.0) preoperatively to 40.0 (IQR 31.5 to 48.0) postoperatively, and 39.0 (IQR 31.5 to 46.5) at long-term follow-up (p < 0.001). Median EQ-5D-3L improved from 0.079 (IQR -0.057 to 0.215) to 0.691 (IQR 0.441 to 0.941) postoperatively, and 0.701 (IQR 0.570 to 0.832) at long-term follow-up (p < 0.001). We found that aROM improved in all planes (p < 0.001). Among the variables assessed on multivariable analysis, a manual occupation, worsening Charlson Comorbidity Index and increasing socioeconomic deprivation were most consistently predictive of worse patient-reported outcome scores. Patients who subsequently developed ON/PTA reported significantly worse one-year and late OSS.
ADROM in patients with persistent symptomatic stiffness following ORPF can achieve excellent short- and long-term outcomes. More deprived patients, those in a manual occupation, and those with worsening comorbidities have worse outcomes following ADROM. Cite this article: 2022;104-B(1):157-167.
切开复位钢板固定(ORPF)治疗移位的肱骨近端骨折可获得可靠的长期疗效。然而,少数患者术后仍存在持续性疼痛和僵硬,可能受益于切开松解、肩峰下减压和金属去除(ADROM)。ADROM 的长期结果尚不清楚;我们旨在评估接受该手术治疗 ORPF 后僵硬的患者的结果,并评估不良预后的预测因素。
1998 年至 2018 年间,424 例连续患者因肱骨近端骨折接受初次 ORPF 治疗。在术后 6 个月时,对有愈合性骨折且有症状的患者提供 ADROM。通过回顾性记录人口统计学数据、骨折特征和并发症,对患者进行随访。记录术前和术后的主动活动范围(aROM)、牛津肩评分(OSS)和 EuroQol 五维三水平问卷(EQ-5D-3L)。
共 138 例患者接受 ADROM 治疗;111 例患者平均随访 10.9 年(1 至 20 年),长期随访。平均年龄为 50.8 岁(18 至 75 岁);79 例(57.2%)为女性。初次 ORPF 至 ADROM 的平均时间为 11.9 个月(6 至 19 个月)。5 例患者发生浅表伤口感染;10 例发生症状性骨坏死/创伤后关节炎(ON/PTA);4 例接受翻修松解术。术前 OSS 中位数从 17(四分位距(IQR)12.0 至 22.0)改善至术后 40.0(IQR 31.5 至 48.0),长期随访时为 39.0(IQR 31.5 至 46.5)(p < 0.001)。术前 EQ-5D-3L 中位数从 0.079(IQR-0.057 至 0.215)改善至术后 0.691(IQR 0.441 至 0.941),长期随访时为 0.701(IQR 0.570 至 0.832)(p < 0.001)。我们发现所有平面的 aROM 均有改善(p < 0.001)。在多变量分析中评估的变量中,手工职业、Charlson 合并症指数恶化和社会经济剥夺程度增加是与患者报告结果评分较差最一致的预测因素。随后发生 ON/PTA 的患者报告 1 年和晚期 OSS 明显较差。
ORPF 后持续性症状性僵硬患者行 ADROM 可获得良好的短期和长期疗效。社会经济地位较低的患者、从事体力劳动的患者和合并症恶化的患者在 ADROM 后预后较差。